Clinical Trials in Salt Lake City

Showing 9861-9880 of 12,670 trials

Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder

NCT01904773

This is a two-part, randomized, multi-center, blinded study in adolescents with Tourette's Disorder. There will be an up to 21-day screening period in which subject eligibility will be determined. In Part 1 of the study, the safety, tolerability and pharmacokinetics of AZD5213 will be assessed during a 1- week period. In Part 2 of the study, the safety, tolerability, and preliminary efficacy of two doses (depending on tolerability in Part 1 of the study) of AZD5213 and placebo will be assessed through six consecutive four-week crossover periods. Each subject will receive both AZD5213 and placebo. A follow-up vist will take place at 14 (±) 7 days following the last dose of study drug.

Tourette Syndrome

AstraZeneca29 participantsStarted Aug 2013

Orange, California, United States • St. Petersburg, Florida, United States • Summit, New Jersey, United States +4 more locations

COMPLETEDPhase 2< 1 mile

A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

NCT00196313

This study is being conducted to evaluate the effects of treatment with Seasonique an extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the typical hormone-free interval. Patients will receive 13 weeks of treatment with the option to extend blinded therapy for an additional 13 weeks. The overall study duration will be 6-9 months. Patients will be required to record menstrual pain in a daily diary.

Dysmenorrhea

Duramed Research95 participantsStarted May 2005

Denver, Colorado, United States • Decatur, Georgia, United States • Louisville, Kentucky, United States +10 more locations

Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder

A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

Find Trials by Condition in Salt Lake City

Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients

Hyperbaric Oxygen Therapy in Chronic Traumatic Brain Injury or Post-Traumatic Stress Disorder

Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant

ASR-XL Metal-on-Metal 522 Post-Market Surveillance Study

Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa

Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations

Depression And Bipolar Disorder

A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics

Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management

Treadmill Training for Spinal Cord Injury

AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure

Checklists and Upright Positioning in Endotracheal Intubation of Critically Ill Patients (Check-UP) Trial

Coronary Artery Bypass Surgery (CABG) Off or On Pump Revascularization Study